Literature DB >> 23162077

Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.

Umar Wazir1, Wael Al Sarakbi, Wen G Jiang, Kefah Mokbel.   

Abstract

UNLABELLED: We studied potential associations between the expression of leptin, leptin receptor (LEPR) and clinicopathological parameters of breast cancer, and the correlation of leptin with human telomerase reverse transcriptase (hTERT) and cyclooxygenase 2 (COX2) PATIENTS AND METHODS: A total of 153 specimens were studied. Transcript levels were determined using quantitative polymerase chain reaction (qPCR), and were correlated with clinicopathological data collected for over 10 years. Additionally, leptin and LEPR expression was studied in several breast cell lines.
RESULTS: Both leptin and LEPR mRNA expression were higher in malignant samples (p=0.0011 and 0.0014 respectively). Both were also expressed in MDA436 and MCF7 cell lines. Leptin showed a significant correlation with LEPR (r=0.504, p=0.0000000222). Leptin did not correlate significantly with clinical stage, tumour grade, or with the expression of hTERT or COX2.
CONCLUSIONS: This study demonstrates that leptin and LEPR are more readily expressed in cancerous tissues suggesting a possible autocrine role in mammary carcinogenesis, which may be independent of hTERT and COX2 genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23162077

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  6 in total

1.  Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.

Authors:  Yunxiu Huang; Qianni Jin; Min Su; Feihu Ji; Nian Wang; Changli Zhong; Yulin Jiang; Yifeng Liu; Zhiqian Zhang; Junhong Yang; Lan Wei; Tingmei Chen; Bing Li
Journal:  Cell Oncol (Dordr)       Date:  2017-08-02       Impact factor: 6.730

2.  The Role of Circulating Adiponectin and SNP276G>T at ADIPOQ Gene in BRCA-mutant Women.

Authors:  Antonella Daniele; Angelo Virgilio Paradiso; Rosa Divella; Maria Digennaro; Margherita Patruno; Stefania Tommasi; Brunella Pilato; Antonio Tufaro; Michele Barone; Carla Minoia; Donatella Colangelo; Eufemia Savino; Porzia Casamassima; Eleonora Bruno; Andreina Oliverio; Patrizia Pasanisi
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

3.  The role of leptin in the ventricular remodeling process and its mechanism.

Authors:  Guoxing Zuo; Xinping Du; Liuying Zheng; Cuancuan Wang; Kuan Wang; Ying Li
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer.

Authors:  Marjory Alana Marcello; Antonio Ramos Calixto; Jacqueline Fatima Martins de Almeida; Mariana Bonjiorno Martins; Lucas Leite Cunha; Camila Ayume Amano Cavalari; Elba C S Etchebehere; Ligia Vera Montalli da Assumpção; Bruno Geloneze; Andre Lopes Carvalho; Laura Sterian Ward
Journal:  Int J Endocrinol       Date:  2015-02-25       Impact factor: 3.257

Review 5.  Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies.

Authors:  Amitabha Ray
Journal:  World J Clin Cases       Date:  2018-10-26       Impact factor: 1.337

6.  Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line.

Authors:  Somaye Dalimi-Asl; Hossein Babaahmadi-Rezaei; Ghorban Mohammadzadeh
Journal:  Iran J Med Sci       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.